Vetropolycin HC Ophthalmic Ointment

View other items in the same category as Vetropolycin HC Ophthalmic Ointment

Product Uses

Vetropolycin HC may be used in acute or chronic conjunctivitis, when caused by organisms susceptible to the antibiotics contained in the ointment. The anti-inflammatory action suppresses inflammation in many disorders of the anterior segment of the eye. Local application to the eye often gives rapid relief of pain and light avoidance, particularly in lesions of the cornea.

Product Contains

Bacitracin zinc, Neomycin sulphate, Polymyxin B Sulfate & hydrocortisone acetate

Dosage and Administration

Apply a thin film over the cornea three or four times daily. The area to be treated should be properly cleansed prior to use. Foreign bodies, crusted exudates and debris should be carefully removed prior to applying medication. Insert the tip of the tube beneath the lower lid and express a small quantity of the ointment into the conjunctival sac in dogs and cats.

Warnings, Side Effects and Drug Interactions

Ophthalmic preparations containing corticosteroids (such as hydrocortisone) are contraindicated in the treatment of those deep, ulcerative lesions of the cornea, as they can delay healing. They are also contraindicated in fungal or viral infections, as they can cause worsening of the disease. Possible side effects attributable to corticosteroids include: excessive drinking and urinating, weight gain, vomiting and diarrhea (occasionally bloody).

Cushing's syndrome has been reported in association with prolonged or repeated corticosteroid therapy in dogs. Inhibition of the body's own steroid production following withdrawal of the drug may occur.

Corticosteroids may induce the first stage of the birth process if used during the last trimester of pregnancy and may precipitate premature labor, which may be associated with complications. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in birth defects in the young.

Incomplete response or exacerbation of disease may be due to the presence of nonsusceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of nonsusceptible organisms, such as fungi. If improvement in the condition is not noted within two or three days, the diagnosis should be reevaluated and appropriate therapeutic measures initiated.

Sensitivity to this ophthalmic ointment is rare, however, if a reaction occurs, such as burning, itching or inflammation, discontinue use of the preparation. Care should be taken not to contaminate the applicator tip during administration of the preparation.